stockrowSummit Therapeutics PLC
SMMT Healthcare Biotechnology
Summit Therapeutics PLC’s revenue for fiscal 2022 (year ended December 2022) was $705,000.00.
- EPS
- +63.2%
- Free cash flow
- −112.8%
Quarter to June 2026, against a year earlier
Follow SMMT
Alert me
Summit Therapeutics PLC (SMMT) Operating margin
Summit Therapeutics PLC's operating margin over the twelve months to 30 June 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from −10,225.4% (fiscal 2022) to 15.5% (fiscal 2019); the current reading is higher than 93% of that period. That is in line with the Biotechnology industry median of 0.00% and in line with the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 0.00% | 0.00 |
| FY2024 | 0.00% | 0.00 |
| FY2023 | 0.00% | 10,225.39 |
| FY2022 | −10,225.4% | (5,461.10) |
| FY2021 | −4,764.3% | 1,420.94 |
| FY2020 | −6,185.2% | (2,487.65) |
| FY2019 | −3,697.6% | (3,713.05) |
| FY2019 | 15.5% | 15.47 |
| FY2018 | 0.00% | 50.45 |
| FY2018 | −50.5% | 2,053.91 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 0.00% | 0.00 |
| Mar 2026 | 0.00% | 0.00 |
| Dec 2025 | 0.00% | 0.00 |
| Sep 2025 | 0.00% | 0.00 |
| 45 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| HALO Halozyme Therapeutics, Inc. compare | 37.4% |
| ASND Ascendis Pharma A/S compare | 24.8% |
| TECH Bio-Techne Corp compare | 20.7% |
| JAZZ Jazz Pharmaceuticals PLC compare | 9.03% |
| BMRN BioMarin Pharmaceutical Inc. compare | 3.12% |
| PCVX Vaxcyte, Inc. compare | 0.00% |
| SMMT Summit Therapeutics PLC | 0.00% |
| KYMR Kymera Therapeutics, Inc. compare | 0.00% |
| BBIO BridgeBio Pharma, Inc. compare | −38.5% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on SMMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement